These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17483948)

  • 1. Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.
    Rigacci L; Nassi L; Puccioni M; Mappa S; Polito E; Dal Pozzo S; Alterini R; Carrai V; Puccini B; Bosi A
    Ann Hematol; 2007 Aug; 86(8):565-8. PubMed ID: 17483948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
    Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
    Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.
    Rummel MJ; Al-Batran SE; Kim SZ; Welslau M; Hecker R; Kofahl-Krause D; Josten KM; Dürk H; Rost A; Neise M; von Grünhagen U; Chow KU; Hansmann ML; Hoelzer D; Mitrou PS
    J Clin Oncol; 2005 May; 23(15):3383-9. PubMed ID: 15908650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.
    de Vos S; Goy A; Dakhil SR; Saleh MN; McLaughlin P; Belt R; Flowers CR; Knapp M; Hart L; Patel-Donnelly D; Glenn M; Gregory SA; Holladay C; Zhang T; Boral AL
    J Clin Oncol; 2009 Oct; 27(30):5023-30. PubMed ID: 19770386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
    Czuczman MS; Koryzna A; Mohr A; Stewart C; Donohue K; Blumenson L; Bernstein ZP; McCarthy P; Alam A; Hernandez-Ilizaliturri F; Skipper M; Brown K; Chanan-Khan A; Klippenstein D; Loud P; Rock MK; Benyunes M; Grillo-Lopez A; Bernstein SH
    J Clin Oncol; 2005 Feb; 23(4):694-704. PubMed ID: 15681517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
    Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
    Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphoma.
    Bauwens D; Maerevoet M; Michaux L; Théate I; Hagemeijer A; Stul M; Danse E; Costantini S; Vannuffel P; Straetmans N; Vekemans MC; Deneys V; Ferrant A; Van Den Neste E
    Br J Haematol; 2005 Nov; 131(3):338-40. PubMed ID: 16225653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit.
    Ben Simon GJ; Cheung N; McKelvie P; Fox R; McNab AA
    Ophthalmology; 2006 Jul; 113(7):1209-13. PubMed ID: 16647129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa.
    Ferreri AJ; Ponzoni M; Martinelli G; Muti G; Guidoboni M; Dolcetti R; Doglioni C
    Haematologica; 2005 Nov; 90(11):1578-9. PubMed ID: 16266908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma of the ocular adnexa: A study of 353 cases.
    Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
    Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
    Sacchi S; Pozzi S; Marcheselli R; Federico M; Tucci A; Merli F; Orsucci L; Liberati M; Vallisa D; Brugiatelli M;
    Cancer; 2007 Jul; 110(1):121-8. PubMed ID: 17503433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K; Prins C; Saurat JH; French LE
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study.
    Martinelli G; Montoro J; Vanazzi A; Andreola G; Liptrott S; Radice D; Negri M; Preda L; Pruneri G; Laszlo D
    Hematol Oncol; 2015 Dec; 33(4):129-35. PubMed ID: 25047267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.
    Herold M; Dölken G; Fiedler F; Franke A; Freund M; Helbig W; Pasold R
    Ann Hematol; 2003 Feb; 82(2):77-9. PubMed ID: 12601483
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma.
    Martinelli G; Laszlo D; Bertolini F; Pastano R; Mancuso P; Calleri A; Vanazzi A; Santoro P; Cavalli F; Zucca E
    Br J Haematol; 2003 Oct; 123(2):271-7. PubMed ID: 14531908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of chemotherapy as a first-line treatment in patients with ocular adnexal MALT lymphoma].
    Ning F; Ye J; Wei LQ; Li X; Wang JW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):912-6. PubMed ID: 22931653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of eight patients with primary follicular lymphoma in the duodenum].
    Tsujioka T; Wada H; Yata K; Kondo T; Suemori S; Tokunaga H; Ohmori K; Kubo Y; Nakanishi H; Mikami M; Haruma K; Sadahira Y; Sugihara T
    Rinsho Ketsueki; 2007 Feb; 48(2):134-9. PubMed ID: 17370641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Six cases of pulmonary MALT lymphoma: a heterogeneous therapeutic management].
    Marco S; Thariat J; Poudenx M; Butori C; Mouroux J; Fuzibet JG; Marquette CH; Peyrade F; Thyss A
    Rev Pneumol Clin; 2011 Jun; 67(3):174-8. PubMed ID: 21665083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.
    Portlock CS; Fischer DS; Cadman E; Lundberg WB; Levy A; Bobrow S; Bertino JR; Farber L
    Cancer Treat Rep; 1987 Nov; 71(11):1029-31. PubMed ID: 3677110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
    Rubenstein JL; Fridlyand J; Abrey L; Shen A; Karch J; Wang E; Issa S; Damon L; Prados M; McDermott M; O'Brien J; Haqq C; Shuman M
    J Clin Oncol; 2007 Apr; 25(11):1350-6. PubMed ID: 17312328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.